Altered Striatal Acetylcholine Dynamics across Dopamine Loss and L-DOPA Treatment
Preprint
Abstract
L-DOPA remains the most effective therapy for Parkinson’s disease (PD), yet its chronic use often induces involuntary movements known as L-DOPA–induced dyskinesia (LID). While abnormal cholinergic interneuron (ChI) activity is a hallmark of both PD and LID, emerging evidence suggests that the temporal organization of acetylcholine (ACh) signaling, rather than its overall magnitude, may determine its functional impact. Under physiological conditions, ChIs exhibit intrinsic delta-frequency activity reflected in coordinated, slow oscillations of extracellular ACh, which are thought to organize striatal network function and movement pattering. To determine how dopamine (DA) depletion and L-DOPA treatment reshape these ACh dynamics, we used in vivo GRAB-ACh fiber photometry in the unilateral 6-OHDA mouse model. DA depletion disrupted slow ACh rhythmicity, reducing delta-band regularity while increasing higher-frequency phasic activity. Acute L-DOPA broadly suppressed ACh activity across frequencies, partially normalizing this imbalance, but without restoring slow temporal structure. In addition, chronic L-DOPA treatment, associated with established dyskinesia, further impaired delta-band coordination in the DA-depleted striatum during the ON state, while OFF-state activity retained lesion-associated features. The anti-dyskinetic agent amantadine restored low-frequency temporal structure both before and after L-DOPA exposure. Together, these findings reveal a state-dependent reorganization of striatal ACh dynamics, characterized by a shift from coordinated slow oscillations to irregular phasic activity following DA loss, and a further breakdown of slow temporal organization during dyskinetic states. These results highlight the temporal structure of cholinergic signaling as a critical and underappreciated dimension of striatal function in PD and LID.Keywords
This publication has 35 references indexed in Scilit:
- Levodopa Disrupts Activity Patterns and Encoding of Movement in Striatal Cholinergic Interneurons of Behaving MiceMovement Disorders, 2025
- Striatal cholinergic transmission in an inducible transgenic mouse model of paroxysmal non-kinesiogenic dyskinesiaNeurobiology of Disease, 2024
- Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: Efficacy negated by co-administration of isradipineExperimental Neurology, 2023
- Levodopa Causes Striatal Cholinergic Interneuron Burst‐Pause Activity in Parkinsonian MiceMovement Disorders, 2021
- A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesiaNeuroscience & Biobehavioral Reviews, 2018
- The striatal cholinergic system in l-dopa-induced dyskinesiasJournal of Neural Transmission, 2018
- Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonistsNeurobiology of Disease, 2016
- Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesiasNeurobiology of Disease, 2016
- Dopamine induced switch in the subthreshold dynamics of the striatal cholinergic interneurons: A numerical studyJournal of Theoretical Biology, 2009
- Pharmacological validation of a mouse model of l-DOPA-induced dyskinesiaExperimental Neurology, 2005